(6R,12aS)-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
更新时间：2024-04-11 22:42:21
![(6R,12aS)-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione结构式](https://image.chemsrc.com/caspic/166/929100-66-3.png)
(6R,12aS)-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione结构式
|
常用名 | (6R,12aS)-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione | 英文名 | (6R,12aS)-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
|---|---|---|---|---|
| CAS号 | 929100-66-3 | 分子量 | 375.37700 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C21H17N3O4 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | (6R,12aS)-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
|---|---|
| 英文别名 | 更多 |
| 分子式 | C21H17N3O4 |
|---|---|
| 分子量 | 375.37700 |
| 精确质量 | 375.12200 |
| PSA | 83.66000 |
| LogP | 2.13580 |
|
~61%
(6R,12aS)-6-ben... 929100-66-3 |
| 文献：Beghyn, Terence; Hounsou, Candide; Deprez, Benoit P. Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 3 p. 789 - 792 |
![(1R,3S)-1-benzo[1,3]dioxol-5-yl-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylic acid methyl ester结构式](https://image.chemsrc.com/caspic/438/629652-44-4.png)
| 上游产品 1 | |
|---|---|
| 下游产品 0 | |
| N-Desmethyl ent-Tadalafil |
本网页内容来自不同专业数据源，如对内容有疑义，欢迎联系service1@chemsrc.com。
